• Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers

    Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers
    Originally published by our sister publication Infectious Disease Special EditionBy Jenny Blair, MD, MS Michael Mina, MD, PhDTwo studies of the anti-SARS-CoV-2 monoclonal antibody pemivibart (Pemgarda, Invivyd) suggest it is safe and effective for pre-exposure prophylaxis (PrEP) among patients with advanced HIV or hematologic malignancies.“For individuals who can’t mount an immune response, this can be a life-saving drug,” said Michael Mina, MD, PhD, the chief medical officer and chief epi
  • Extending BCMA Into the OR Tests Workflow—and Culture

    Extending BCMA Into the OR Tests Workflow—and Culture
    By Gina ShawBringing barcode medication administration (BCMA) into ORs remains one of medication safety’s most persistent challenges, but one that is increasingly achievable with the right preparation, multidisciplinary buy-in, and workflow flexibility, according to presenters at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas. The experiences of several health systems demonstrate how perioperative care teams are tackling the logistical barriers to close the gap in BCMA a

Follow @newsl_pharmacy on Twitter!